SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · IEX Real-Time Price · USD
4.590
-0.050 (-1.08%)
Jul 2, 2024, 4:30 PM EDT - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $300.07 million as of July 2, 2024. Its market cap has increased by 21.63% in one year.
Market Cap
300.07M
Enterprise Value
213.78M
1-Year Change
21.63%
Ranking
Category
Stock Price
$4.59
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $300.07M, a decrease of -73.22%. That is a compound annual growth rate of -36.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 303.30M | -1.14% |
| Dec 29, 2023 | 306.80M | 131.90% |
| Dec 30, 2022 | 132.30M | -85.31% |
| Dec 31, 2021 | 900.40M | -19.63% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nevro | 309.26M |
| TScan Therapeutics | 309.25M |
| Verrica Pharmaceuticals | 309.24M |
| ADC Therapeutics | 304.07M |
| Spok Holdings | 299.84M |
| Zynex | 296.14M |
| Nautilus Biotechnology | 293.12M |
| Orchestra BioMed Holdings | 291.68M |